AI assistant
PFIZER INC — Director's Dealing 2021
Mar 2, 2021
29831_dirs_2021-03-02_29c2d259-bfe9-4df8-a1fc-056d821c2147.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-27
Reporting Person: YOUNG JOHN D (Group President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-27 | Common Stock | M | 129419.0000 | $22.3500 | Acquired | 575282.0000 | Direct |
| 2021-02-27 | Common Stock | F | 23194.0000 | $33.4900 | Disposed | 552088.0000 | Direct |
| 2021-02-27 | Common Stock | F | 82057.0000 | $34.6400 | Disposed | 470031.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-27 | Stock Appreciation Rights | $22.3500 | M | 129419.0000 | Disposed | 2021-02-27 | Common Stock (129419.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2446.0000 | Indirect |
| Common Stock | 1589.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: Price is the closing price of Pfizer common stock on February 26, 2021.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.